☕ XOXO, VC Tea 👑
October 17, 2026 | Sand Hill Road's Daily Digest
|
|
Hey Upper East Siders (and Sand Hill Road): the checks are going into construction, RNA, and gene therapy, while one AI-coding darling says it has quietly dumped its model provider. But in venture, darlings, even a breakup has two sides. Pour something dark.
|
💸 The Freshest Checks on the Block
Icon prints $200M for construction robotics
Austin-based Icon, known for robotic construction systems and 3D-printed homes, closed a $200M Series D led by Baillie Gifford and BlackRock. The company says it is on pace for 4x revenue growth in 2026—a construction-tech flex that now has to prove it can scale. [Crunchbase News]
Estuary arrives with $103M
Menlo Park’s Estuary Biotherapeutics launched with $103M in financing for genetic medicines targeting serious kidney diseases: a $93M Series A led by RA Capital plus $10M in previously undisclosed seed capital. [Crunchbase News]
Soufflé serves up $135M
Boston RNA-therapy developer Soufflé Therapeutics raised a $135M Series B led by Juvia Group. The syndicate is large; the headline check is already entrée-sized. [Crunchbase News]
|
🎭 The Breakups & Boardroom Whispers
Replit’s Anthropic breakup has a witness problem
CEO Amjad Masad said Replit is no longer working with Anthropic, citing several reasons including cost. But a source familiar with the relationship told TechCrunch the partnership was still in place, and Replit’s late-September materials listed Claude models in production. Status: it’s complicated. [TechCrunch: Replit]
a16z redraws its ‘full-stack talent’ org chart
Axios reports Andreessen Horowitz laid off a majority of its 34-person centralized team that helped portfolio companies recruit; remaining staff are being reassigned to investment groups. The firm declined comment. A founder-service selling point is getting a makeover, darling. [Axios]
|
🪙 New Money, New Rules
Nauta’s sixth fund opens at €60M
European B2B software and deep-tech investor Nauta closed €60M for Fund VI, anchored by a €30M commitment from the British Business Bank. Three-quarters of first-close LPs are returning; the target is €150M–€200M by the second half of 2027. Familiar capital, longer runway. [EU-Startups]
Peter Diamandis makes a concentrated biology bet
Diamandis and cancer biologist and managing partner Yianni Psaltis launched NeoGenesis Capital and announced an initial close of Fund I. It plans to invest in Colossal Biosciences and companies spun from its programmable-biology platform; the announcement does not disclose fund size. Diamandis also disclosed he was an early Colossal investor. One ecosystem, by design. [NeoGenesis Capital]
|
🗣️ What the VCs Are Saying
Amulya Vishwanath: robotics is still in its ‘Lego era’
Techable VC’s founder and managing partner says actuators, robotic hands, software, and safety standards are still being rebuilt. Her counter to the coming-ChatGPT-moment chorus: back the physical-AI building blocks, not just the promise of one magic model. [TechCrunch: Equity]
Ben Narasin: AI will be ‘bigger than electricity’
Tenacity Venture Capital’s founder and GP made the bullish case on CNBC while discussing the AI buildout, revenue race, and IPO market. It is a grand thesis—and a reminder that investors will eventually ask where the durable revenue lands. [CNBC]
Shilpi Nayak: buy the intelligence layer beneath the robots
The 434VC GP argues the interesting companies may be the data engines, foundation models, and perception hardware that let machines act in the messy real world—not the robots alone. Brain before body: a very different place to put the next check. [X: Shilpi Nayak]
|
🧭 The Bottom Line
Fewer mega-rounds, but no shortage of conviction
Crunchbase counted just two startup financings in the multiple-hundreds-of-millions range last week. The rest of its biggest-round list still had nine-figure biotech checks beside Icon’s construction-tech raise: concentrated capital, not a capital strike. [Crunchbase News]
The moat debate is the real tea
Narasin is betting on a buildout bigger than electricity; Vishwanath says robotics still needs its Lego bricks; Nayak is watching the intelligence layer. The diligence question is no longer merely ‘Is it AI?’—it’s which layer owns the customer, economics, and staying power. [CNBC, TechCrunch: Equity, X: Shilpi Nayak]
|
|
The tea? Capital still loves hard problems, but the real plot is where the moat sits: power, product, components, or the intelligence layer. Keep your friends close and your customer economics closer. Have a verified tip? Just hit reply; I’ll keep names out unless you ask for credit.
You know you love me,
XOXO
Your VC Gossip Girl 💋
|
|
Sources:
Crunchbase News — weekly funding rounds
TechCrunch — Replit and Anthropic
Axios — a16z recruiting team
EU-Startups — Nauta Fund VI
NeoGenesis Capital — Fund I announcement
TechCrunch Equity — Amulya Vishwanath
CNBC — Ben Narasin
X — Shilpi Nayak
|
|
